» Articles » PMID: 15448136

Sharp-1/DEC2 Inhibits Skeletal Muscle Differentiation Through Repression of Myogenic Transcription Factors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Sep 28
PMID 15448136
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal muscle differentiation is regulated by the basic-helix-loop-helix (bHLH) family of transcription factors. The myogenic bHLH factors form heterodimers with the ubiquitously expressed bHLH E-proteins and bind E-box (CANNTG) sites present in the promoters of several muscle-specific genes. Our previous studies have shown that the bHLH factor Sharp-1 is expressed in skeletal muscle and interacts with MyoD and E-proteins. However, its role in regulation of myogenic differentiation remains unknown. We report here that endogenous Sharp-1 is expressed in proliferating C2C12 myoblasts and is down-regulated during myogenic differentiation. Constitutive expression of Sharp-1 in C2C12 myoblasts promotes cell cycle exit causing a decrease in cyclin D1 expression but blocks terminal differentiation. Although MyoD expression is not inhibited, the induction of differentiation-specific genes such as myogenin, MEF2C, and myosin heavy chain is impaired by Sharp-1 overexpression. We demonstrate that the interaction of Sharp-1 with MyoD and E-proteins results in reduced DNA binding and transactivation from MyoD-dependent E-box sites. Re-expression of MyoD approximately E47 rescues the differentiation defect imposed by Sharp-1, suggesting that myogenic bHLH factors function downstream of Sharp-1. Our data suggest that protein-protein interactions between Sharp-1, MyoD, and E47 resulting in interference with MyoD function underlies Sharp-1-mediated repression of myogenic differentiation.

Citing Articles

BHLHE41, a transcriptional repressor involved in physiological processes and tumor development.

Bret C, Desmots-Loyer F, Moreaux J, Fest T Cell Oncol (Dordr). 2024; 48(1):43-66.

PMID: 39254779 PMC: 11850569. DOI: 10.1007/s13402-024-00973-3.


Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins.

Amissah H, Combs S, Shevtsov M Cells. 2024; 13(13.

PMID: 38994941 PMC: 11240553. DOI: 10.3390/cells13131087.


ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.

Sicinska E, Kola V, Kerfoot J, Taddei M, Al-Ibraheemi A, Hsieh Y Cancer Res. 2024; 84(14):2247-2264.

PMID: 38657118 PMC: 11250573. DOI: 10.1158/0008-5472.CAN-23-2115.


Approach to Functions of in Non-Small Lung Cancer Development.

Furukawa T, Mimami K, Nagata T, Yamamoto M, Sato M, Tanimoto A Int J Mol Sci. 2023; 24(14).

PMID: 37511489 PMC: 10380948. DOI: 10.3390/ijms241411731.


Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis.

Lucchini M, De Arcangelis V, Santoro M, Morosetti R, Broccolini A, Mirabella M Int J Mol Sci. 2023; 24(13).

PMID: 37446317 PMC: 10342054. DOI: 10.3390/ijms241311139.